Biotech
Acer Inc.
Products, Pipelines & Platforms
- AIL-111 is a proprietary ionizable lipid platform featuring high transfection efficiency and a uniquely tunable
formulation design. This flexibility enables broad mRNA applications. - aiAntigen leverages integrated NGS processing and advanced Al to streamline
the path from mutation identification to personalized immunotherapy.
Interests
- Clinical Trial Collaboration
- Out-Licensing
- Collaborative R&D
- Strategic Alliance
Contact Information
- NameTsung-Hsien (Vincent) Tsai
- PositionSenior Manager
- Tel+886-937-005648
- Emailvincent.tsai@acer.com
- https://www.acer.com/